These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18172901)

  • 1. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
    Jeremić B; Milicić B
    Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
    Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.
    Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
    J Clin Oncol; 1996 Apr; 14(4):1065-70. PubMed ID: 8648358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiochemotherapy of non-small-cell bronchial carcinoma. A report of experience].
    Müller G; Kiricuta IC; Stiess J; Flentje M
    Strahlenther Onkol; 1996 Aug; 172(8):446-54. PubMed ID: 8765348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
    Jeremic B; Shibamoto Y; Acimovic L; Djuric L
    J Clin Oncol; 1995 Feb; 13(2):452-8. PubMed ID: 7844608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.
    Ball D; Bishop J; Smith J; Crennan E; O'Brien P; Davis S; Ryan G; Joseph D; Walker Q
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):267-72. PubMed ID: 7836079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.
    Safran H; King T; Choy H; Gollerkeri A; Kwakwa H; Lopez F; Cole B; Myers J; Tarpey J; Rosmarin A
    Cancer; 1996 Sep; 78(6):1203-10. PubMed ID: 8826941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer.
    Jeremic B; Jevremovic S; Mijatovic L; Milisavljevic S
    Cancer; 1993 Jun; 71(11):3732-6. PubMed ID: 8387885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of daily administration of oral etoposide for non-small cell lung cancer treated with concurrent radiation therapy].
    Ohnishi H; Okada J; Yamaguchi M; Ogata H; Hatano K; Takizawa Y; Imai Y; Hara R; Araki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):510-4. PubMed ID: 9267140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer.
    Byhardt RW
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1513-25. PubMed ID: 7635796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
    Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
    J Clin Oncol; 1997 Mar; 15(3):893-900. PubMed ID: 9060525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of daily low-dose carboplatin in radiotherapy for non-small cell lung cancer.
    Satoh H; Ohara K; Fuji H; Ishikawa H; Yamashita YT; Kamma H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1998; 18(6B):4625-7. PubMed ID: 9891530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.
    Jeremic B; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):303-8. PubMed ID: 8567330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15.
    Byhardt RW; Scott CB; Ettinger DS; Curran WJ; Doggett RL; Coughlin C; Scarantino C; Rotman M; Emami B
    Cancer; 1995 May; 75(9):2337-44. PubMed ID: 7712445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.
    Werner-Wasik M; Scott C; Graham ML; Smith C; Byhardt RW; Roach M; Andras EJ
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):327-31. PubMed ID: 10760427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy.
    Jeremic B; Shibamoto Y
    Lung Cancer; 1995 Aug; 13(1):21-30. PubMed ID: 8528637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.